Oxular's innovative technology enables sustained drug release, better delivery, and reduced side effects, while improving therapeutic effectiveness, the company claims.

Its product development pipeline includes new treatments for prevalent retinal diseases, such as diabetic macular edema, rare and ophan conditions including ocular cancers and delivery of gene therapy.